Fernando Gaion
Publications by Year
Research Areas
Hepatocellular Carcinoma Treatment and Prognosis, Lung Cancer Treatments and Mutations, Colorectal Cancer Treatments and Studies, Bone health and treatments, Cancer Treatment and Pharmacology
Most-Cited Works
- → The Role of UGT1A1*28 Polymorphism in the Pharmacodynamics and Pharmacokinetics of Irinotecan in Patients With Metastatic Colorectal Cancer(2006)333 cited
- → Efficacy and safety of 12-weekly versus 4-weekly zoledronic acid for prolonged treatment of patients with bone metastases from breast cancer (ZOOM): a phase 3, open-label, randomised, non-inferiority trial(2013)197 cited
- → A randomized trial of intensive versus minimal surveillance of patients with resected Dukes B2-C colorectal carcinoma(2015)131 cited
- → Pathological complete response rates following different neoadjuvant chemotherapy regimens for operable breast cancer according to ER status, in two parallel, randomized phase II trials with an adaptive study design (ECTO II)(2011)52 cited
- → Surgery Followed by Intracavitary plus Systemic Chemotherapy in Malignant Pleural Mesothelioma(1996)41 cited
- → Weekly Vinorelbine in Elderly Patients with Non-Small-Cell Lung Cancer(1994)24 cited
- → Medical Treatment of Hepatocellular Carcinoma: Any Progress?(1994)21 cited
- → Stanford V Regimen plus Consolidative Radiotherapy Is an Effective Therapeutic Program for Bulky or Advanced-Stage Hodgkin’s Disease(2004)12 cited
- → Pain at Tumor Site after Vinorelbine Injection: Description of an Unexpected Side Effect(1995)12 cited
- → ZOOM: A prospective, randomized trial of zoledronic acid (ZOL; q 4 wk vs q 12 wk) for long-term treatment in patients with bone-metastatic breast cancer (BC) after 1 yr of standard ZOL treatment.(2012)11 cited